Karolinska Institutet
Browse

File(s) not publicly available

Molecular mechanisms in amyloid fibril formation

thesis
posted on 2024-09-03, 02:30 authored by Waltteri Hosia

This thesis concerns investigations on molecular processes and interactions that lead to amyloid fibril formation. Pulmonary surfactant protein C (SP-C), and a synthetic analogue thereof, SP-C(Leu), have similar properties in terms of charge distribution, hydrophobicity and secondary structure, yet they differ in their aggregation propensities.

These peptides were studied by hydrogen/deuterium exchange (HDX) MALDI mass spectrometry (MS). SP-C, but not SP-C(Leu) resists HDX and the ion current of SP-C but not of SP-C(Leu) was lost because of formation of insoluble aggregates. This suggests that SP-C has a high barrier of refolding to alpha-helix, responsible for the difference in aggregation ability of these similar peptides. A recently isolated biosynthetic precursor of SP-C, SP-Ci, has a 12-residue N-terminal propeptide followed by the SP-C sequence. It was observed that the propeptide locks the metastable SP-C in a helical conformation. The SP-Ci does not unfold or aggregate in neutral solution during several weeks of incubation, as judged by HDX and MS.

However, in an acidic environment SP-Ci unfolds and forms amyloid fibrils like SP-C. These data suggest a stabilizing role for the N-term inal propeptide in SP-C biosynthesis. Amyloid P-peptide (Abeta) is suggested to be responsible for Alzheimer's disease. The aggregation profile of Abeta(1-40) studied by electrospray ionisation (ESI) -MS, shows first order kinetics of Abetaaggregation. During the experiment, acid-catalysed spontaneous cleavage of Abeta(1 -40), most prominently at 23(Asp)-24(Val) was observed. Moreover, Abeta(24-40) was found to be unexpectedly stable in solution.

The tetrapeptides KFFE and KVVE can form fibrils, which are practically identical to fibrils formed in association with amyloid diseases. Other peptides studied, especially KLLE, KAAE, KFFK and EFFE did not form fibrils. In order to form fibrils the tetrapeptides thus need P-sheet promoting amino acids, and charge attraction from oppositely charged side chains. Attaching two KFFE sequences with either AAAK (supposedly random) or YNGK (frequent in betaturns) produces 12-mer peptides KFFEAAAKKFFE and KFFEYNGKKFFE. Freshly dissolved KFFEAAAKKFFE is monomeric and shows a random secondary structure, but upon incubation it forms abundant amyloid fibrils. Conversely, peptide KFFEYNGKKFFE does not form fibrils, but folds into a stable beta-hairpin structure. The results suggest that the tendency of polypeptides to form amyloid fibrils can depend on the structural context of an arnyloidogenic subsequence.

List of scientific papers

I. Hosia W, Johansson J, Griffiths WJ (2002). Hydrogen/deuterium exchange and aggregation of a polyvaline and a polyleucine alpha-helix investigated by matrix-assisted laser desorption ionization mass spectrometry. Mol Cell Proteomics. 1(8): 592-7.
https://pubmed.ncbi.nlm.nih.gov/12376574

II. Li J, Hosia W, Hamvas A, Thyberg J, Jornvall H, Weaver TE, Johansson J (2004). The N-terminal Propeptide of Lung Surfactant Protein C is Necessary for Biosynthesis and Prevents Unfolding of a Metastable alpha-Helix. J Mol Biol. 338(5): 857-62.
https://pubmed.ncbi.nlm.nih.gov/15111052

III. Hosia W, Griffiths W, Johansson J (2004). Hydrolysis of the amyloid beta-peptide (Abeta)1-40 between Asp23-Val24 produces non-aggregating fragments. An electrospray mass spectrometry study. [Submitted]

IV. Tjernberg L, Hosia W, Bark N, Thyberg J, Johansson J (2002). Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptides. J Biol Chem. 277(45): 43243-6. Epub 2002 Sep 04
https://pubmed.ncbi.nlm.nih.gov/12215440

V. Hosia W, Bark N, Liepinsh E, Tjernberg A, Persson B, Hallen D, Thyberg J, Johansson J, Tjernberg L (2004). Folding into a beta-hairpin can prevent amyloid fibril formation. Biochemistry. 43(16): 4655-61.
https://pubmed.ncbi.nlm.nih.gov/15096033

History

Defence date

2004-06-11

Department

  • Department of Medical Biochemistry and Biophysics

Publication year

2004

Thesis type

  • Doctoral thesis

ISBN-10

91-7349-976-5

Number of supporting papers

5

Language

  • eng

Original publication date

2004-05-21

Author name in thesis

Hosia, Waltteri

Original department name

Department of Medical Biochemistry and Biophysics

Place of publication

Stockholm

Usage metrics

    Theses

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC